PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab with VEGF TKI cabozantinib in metastatic untreated REnal Cell CancEr (Alliance A031704)

Image

2020 PDIGREE ASCO

Contact

For more information on this presentation, please contact:

Tian Zhang, MD, MHS
Twitter: @TiansterZhang
Email: Tian Zhang